How long does semaglutide take to suppress appetite — and what shapes that timeline?

The decision most people face: do I wait for the full dose, or is something happening already?

A question our prescribers hear most weeks is some version of: "I've had my first injection and I don't feel any different, is it working?" It's the right thing to ask. The 0.25mg starting dose is calibrated for tolerability, not for maximum effect. Its job is to let your system adjust before the dose climbs. So if week one feels unremarkable on the hunger front, that's expected rather than a sign the medicine isn't working for you.

What most people do notice at the lower doses is subtler than a dramatic drop in appetite: food becomes slightly less compelling, portion sizes feel adequate sooner, or the urge to snack between meals quietly fades. These early signals are worth paying attention to, because they indicate the GLP-1 pathway is engaged. If you're wondering how quickly semaglutide reduces appetite at each stage, the answer depends as much on where you are in the titration as on the calendar, a pattern that also shapes the full picture of how quickly Wegovy suppresses appetite.

The practical upshot: don't judge the medicine by the first pen. The appetite effect compounds as the dose rises. By the time most people reach 1.7mg or 2.4mg, the change in hunger cues is usually clear enough to anchor new eating habits around.

What the clinical evidence shows about appetite and timing

The STEP 1 trial, published in the New England Journal of Medicine, followed adults with obesity on 2.4mg semaglutide for 68 weeks. Average body-weight reduction was around 15%, but the participant data also showed that changes in subjective appetite and food preference appeared early in treatment, well before the larger weight changes accumulated. That pattern fits the pharmacology: semaglutide's half-life means steady-state blood levels are reached within four to five weeks at a given dose, at which point the appetite signal is at its most consistent.

The titration schedule itself therefore creates a stepped appetite effect. Each dose increase typically brings a modest further reduction in hunger, sometimes accompanied by a brief return of nausea as the body adapts. Understanding this helps set realistic expectations: semaglutide isn't switching appetite off in week one, it's progressively recalibrating it over several months. People who reach the 2.4mg maintenance dose and stay there report the most stable appetite suppression, which is consistent with NHS guidance on semaglutide's mechanism and use.

If you're curious how the newer 7.2mg maintenance dose compares on appetite and weight outcomes, how long Wegovy takes to work overall covers the broader evidence.

The factors that shift your personal timeline

Not everyone follows the same arc. Several variables determine whether appetite suppression arrives early and strongly or builds more slowly.

Gastric emptying rate plays a part. Semaglutide slows how quickly food leaves the stomach, which extends the feeling of fullness. People who naturally have faster gastric emptying may notice this effect more sharply at lower doses. Body composition matters too: a higher starting weight means more receptor-mediated hormonal noise to work through, which can delay the subjective sense that appetite has changed even when the biology is responding.

Titration pace is another factor worth understanding. The standard schedule moves in roughly four-week steps. Some people tolerate escalation well and arrive at 2.4mg with few side effects; others need more time at an intermediate dose to manage nausea. That's a clinical decision for your prescriber, slowing the titration doesn't mean the treatment isn't working, and it can protect the appetite-suppressing gains you've already made. You can read more about how long before Wegovy suppresses appetite in our related guide, which also covers what happens if progress feels slower than expected.

For context on how the cost of treatment fits into a longer timeline of use, our Wegovy pricing guide explains what a full course typically involves.

When appetite suppression isn't enough on its own

Semaglutide's appetite effect is a mechanism, not a complete plan. The clinical trials that demonstrated 15% average weight loss ran alongside dietary and activity support, the medicine creates the space (smaller portions feel satisfying, cravings quiet down), but building habits inside that space is what makes the loss durable.

If you've been on a stable maintenance dose for twelve weeks or more and hunger hasn't shifted meaningfully, that's worth raising with your prescriber rather than assuming it's a personal failing. A small number of people don't respond as expected; others find the effect is there but masked by stress, disrupted sleep or irregular eating patterns that undermine it. There's also emerging research, such as the BELIEVE trial results, exploring what combination approaches might add where semaglutide alone doesn't achieve the expected outcome.

If you're weighing up whether semaglutide or tirzepatide might be the better fit for you, our weight-loss treatment overview sets out the options plainly. And if you're ready to talk it through with a prescriber, you can check your eligibility with a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber, not a scoring algorithm.